PPARG and obesity due to melanocortin 4 receptor deficiency: In the light of the recent findings, it has become clear that, besides activating PPARγ in the adipocyte, pharmacological activation of this receptor extends to a much broader range of cell types, such as T regulatory cells, which is likely beneficial in the suppression of obesity-associated inflammation in white adipose tissue, as far as rodents are concerned.